Berapa harga NightHawk Biosciences, Inc. (NHWK)

Harga NightHawk Biosciences, Inc. (NHWK) adalah $0.3136

Apa kapitalisasi pasar NightHawk Biosciences, Inc. (NHWK)

Kapitalisasi pasar NightHawk Biosciences, Inc. (NHWK) adalah $7.97M

NightHawk Biosciences, Inc. (NHWK) Dividen

NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.

Tahun	Dividen (disesuaikan dengan stock split)	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen (disesuaikan dengan stock split)

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Tahun	Dividen	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Jumlah pembayaran dividen	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	29.00%	BE

Perusahaan

Jumlah pembayaran dividen

Negara